Global Bioresorbable Vascular Scaffold Market Size is valued at USD 179.7 Mn in 2024 and is predicted to reach USD 375.6 Mn by the year 2034 at a 7.8% CAGR during the forecast period for 2025-2034.
The market for bioresorbable scaffolds is growing due to an increase in acceptance of cardiovascular procedures due to the advantages provided, including full body absorption and an increase in lifestyle-related disorders like diabetes and obesity. The rise also influences the market for bioresorbable scaffolds in adopting unhealthy lifestyle habits like drinking alcohol, eating poorly, and not exercising, as well as advancements developed by major industry players to help arteries function normally again.
Additionally, the market for bioresorbable scaffolds is favourably impacted by changing lifestyles, population expansion, an increase in cardiovascular procedures, and rising healthcare costs. Research and development efforts to stop vascular recoil that permits anti-proliferative medication release to expand the lucrative potential for the bioresorbable.
Another element projected to contribute to the target market's growth during the projected period is the development of novel bioresorbable vascular scaffolds that aid patients with cardiovascular disorders. Furthermore, new product technologies, various products in development, and increased demand for biocompatible and safe coronary stents are other factors anticipated to fuel market expansion globally throughout the forecast period.
The bioresorbable vascular scaffold market is segmented based on product, diseases type, material type and end users. As per the product, the market is segmented as everolimus-eluting devices, novolimus-eluting devices, and sirolimus-eluting devices. The market is segmented as coronary and peripheral artery disease based on disease type. The market is segmented as Poly-L-Lactic Acid (PLLA), Tyrosine-derived Polycarbonate and Others based on material type. End users segment the market into hospitals, ambulatory surgical centres, cardiac catheterization labs and others.
The coronary artery disease category will hold a major share of the global bioresorbable vascular scaffold market in 2024. A bioresorbable vascular scaffold treats coronary and peripheral arterial obstruction related to coronary heart disease, ischemic heart disease, and other cardiovascular illnesses. The rising frequency of coronary heart disease, ischemic heart disease, and other cardiovascular disorders is predicted to raise demand for the bioresorbable vascular scaffold, ultimately fueling industrial expansion.
The hospital segment is likely to grow rapidly in the global bioresorbable vascular scaffold market. The primary source of money for the entire healthcare industry, which supports research and innovation, is the hospital sector, which is significant to the healthcare system. Thus, businesses are working hard to promote their goods and services at hospitals from a financial and marketing perspective. As a result of their enhanced patient care, hospitals have experienced profitable expansion.
As individuals get older, their immune systems decline, and they become more prone to illnesses and disorders, which increases the need for hospitals; there is an increasing need for frequent access to healthcare services. The region's well-developed healthcare infrastructure, which includes hospital beds, equipment, and increased government funding, is anticipated to hasten the growth of the hospitals.
The North American bioresorbable vascular scaffold market is expected to record the maximum market share in revenue shortly. This can be attributed to the sturdy focus on the environment in the region, with the growing adoption of Bioresorbable Vascular scaffolds in different industries, including food & beverages, personal care, packaging, automotive, and others. In addition, the region's chemical industry is focusing on producing Bioresorbable Vascular Scaffolds to develop sustainable and environmentally-friendly solutions.
The region's target market is expanding as a result of factors including rising demand for bio-based components across sectors and growing use of bioresorbable vascular scaffolds in the manufacturing of intermediate chemicals. In addition, Europe is anticipated to have tremendous growth. The elderly population in the area is growing swiftly, and obesity, coronary artery disease, peripheral artery disease, and heart disease are all on the rise.
| Report Attribute | Specifications |
| Market size value in 2024 | USD 179.7 Mn |
| Revenue forecast in 2034 | USD 375.6 Mn |
| Growth rate CAGR | CAGR of 7.8% from 2025 to 2034 |
| Quantitative units | Representation of revenue in US$ Million, volume (number of units) and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments covered | By Product Type, By Disease Type, By Material Type, By End-User. |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | BIOTRONIK Group of Companies, Meryl Life Sciences Pvt. Ltd., Kyoto Medical Planning Co., Ltd., Elixir Medical, Zorin Medical |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Bioresorbable Vascular Scaffold Market By Product Type
Bioresorbable Vascular Scaffold Market By Disease Type
Bioresorbable Vascular Scaffold Market By Material Type
Bioresorbable Vascular Scaffold Market By End-user
Bioresorbable Vascular Scaffold Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.